Recommended dietary allowance of folic acid sufficient for low homocysteine level;Aanbevolen dagelijkse hoeveelheid foliumzuur onvoldoende voor optimale homocysteinespiegels

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 14, 1998, Pages 782-786

  Brouwer, D A J ^a,b   Welten, H T M E ^a   Van Doormaal, J J ^a,c   Reijngoud, D J ^a,d   Muskiet, F A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Centraal Klin Chemisch Laboratorium

^c Atherosclerose Lipiden Polikliniek ^*

^d Laboratorium voor Metabole Ziekten

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; NORMAL HUMAN; NUTRITIONAL REQUIREMENT; RISK MANAGEMENT; VITAMIN INTAKE;

ADULT; AGED; ARTERIOSCLEROSIS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NUTRITION POLICY; PROSPECTIVE STUDIES; PYRIDOXINE; REFERENCE VALUES;

EID: 0032481893     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nederlandse Voedingsnormen 1989. Foliumzuur. 2e dr. Den Haag: Voorlichtingsbureau voor de Voeding, 1992.
2. Food and Nutrition Board. Recommended dietary allowances. 10th ed Washington: National Academic Press, 1989.
3. Vervolgadvies inzake foliumvoorziening in relatie tot neuraalbuisdefecten. Den Haag: Gezondheidsraad/Voedingsraad, 1993.
4. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;74:1049-57.
5. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
6. Verhoef P. B-vitamins and cardiovascular disease Epidemiologic evidence [proefschrift] Wageningen: Landbouwuniversiteit, 1996.
7. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease Int J Epidemiol 1995;24:704-9.
8. Boers GHJ Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease. Neth J Med 1994;45:34-41
9. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease The European Concerted Action Project. JAMA 1997;277: 1775-81
10. Heijer M den. Blom HJ. Hyperhomocysteïnemie: achtergrond. diagnostiek en behandeling. Nederlands Tijdschrift voor Klinische Chemic 1996;21:37-40.
11. Engbersen AM, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-50.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation at the methylenetetrahydrofolate reductase [letter]. Nat Genet 1995;10:111-3.
13. Kluijimans LAJ, Kastelijn JP, Lindemans J, Boers GHJ, Heil SG, Bruschke AVG, et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Nederlands Tijdschrift voor Klinische Chemie 1997;22:141.
14. Rasmussen K, Møller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.
15. Brattström LE, Israelsson B, Jeppsson JO, Hultberg BL. Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-21.
16. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction, relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-59.
17. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
18. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
19. Schrijver J, Speek AJ, Schreurs WHP Semi-automated fluorometric determination of pyridoxal-5′-phosphate (vitamin B6) in whole blood by high-performance liquid chromatography (HPLC). Int J Vitam Nutr Res 1981;51:216-22.
20. Ubbink JB, Serfontein WJ, Villiers LS de. Stability of pyridoxal-5-phosphate semicarbazone: applications in plasma vitamin B6 analysis and population surveys of vitamin B6 nutritional status. J Chromatogr 1985;342:277-84.
21. Whitby LG, Smith AF, Beckett GJ. Lecture notes in clinical chemistry 4th ed. Oxford: Blackwell Scientific Publications, 1988:17-37.
22. Garg UC, Zheng ZJ, Folsom AR, Moyer YS, Tsai MY, McGovern P, et al. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 1997;43:141-5.
23. Houwelingen JC, Stijnen Th, Strik R van. Inleiding in de medische statistiek. 2e dr. Utrecht: Bunge, 1995.
24. Blom HJ, Boers GHJ, Eskes TKAB, Trijbels JMF, Hyperhomocysteinemie Nederlands Tijdschrift voor Klinische Chemie 1995;20: 20-6.
25. Bausch-Goldbohm RA, Hulshof KFAM, Brants HAM, Berg H van den, Bouman M. De inneming van foliumzuur door verschillende bevolkingsgroepen in Nederland voor en na verrijking van bepaalde voedingsmiddelen. Voedselconsumptiepeiling 1992. Zeist. TNO, 1995.